Luigi Francesco Agnati

Luigi Francesco Agnati's AcademicInfluence.com Rankings

Biology

#4954

World Rank

#7309

Historical Rank

Physiology

#107

World Rank

#249

Historical Rank

biology Degrees

Download Badge

Biology

Luigi Francesco Agnati's Degrees

Doctorate Medicine University of Modena and Reggio Emilia
PhD Pharmacology University of Modena and Reggio Emilia

Why Is Luigi Francesco Agnati Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Luigi Francesco Agnati's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intercellular communication in the brain: Wiring versus volume transmission (1995) (560)
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA (2009) (540)
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. (1985) (538)
Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors* (2002) (506)
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. (1986) (466)
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. (2000) (464)
Targeting adenosine A2A receptors in Parkinson's disease (2006) (430)
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization (2003) (427)
Volume transmission in the CNS and its relevance for neuropsychopharmacology. (1999) (332)
Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons (2003) (323)
Detection of heteromerization of more than two proteins by sequential BRET-FRET (2008) (296)
Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. (1983) (291)
Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia 1 Published on the World Wide Web on 12 January 1998. 1 (1998) (283)
The discovery of central monoamine neurons gave volume transmission to the wired brain (2010) (255)
Receptor heteromerization in adenosine A2A receptor signaling (2003) (254)
Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. (1988) (253)
GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system (1983) (250)
The emergence of the volume transmission concept 1 Published on the World Wide Web on 12 January 1998. 1 (1998) (249)
Adenosine receptor–dopamine receptor interactions in the basal ganglia and their relevance for brain function (2007) (246)
Understanding wiring and volume transmission (2010) (246)
C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. (2010) (239)
Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. (1983) (224)
From the Golgi–Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission (2007) (218)
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function (2007) (210)
Volume transmission in the brain. Novel mechanisms for neural transmission Edited by K. Fuxe and L.F. Agnati, Advances in neuroscience vol. 1, Raven Press, New York, 1991, 602 pp., US$ 130,- (1992) (204)
Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology (2008) (195)
Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. (2004) (194)
Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection. (1980) (194)
Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis (1992) (194)
Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. (1978) (183)
Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer (2003) (178)
Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata (1983) (174)
Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. (1983) (170)
Rapid important paper on the cellular localization and distribution of estrogen receptors in the rat tel- and diencephalon using monoclonal antibodies to human estrogen receptor (1986) (168)
Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines (1987) (167)
Evidence for Adenosine/Dopamine Receptor Interactions: Indications for Heteromerization (2000) (166)
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis (2008) (165)
Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system (1994) (164)
Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. (1981) (160)
Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors (1975) (160)
Chronic antidepressant treatment and central 5-HT synapses (1983) (157)
Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. (1983) (157)
Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications (1989) (152)
Receptor‐receptor interactions in the central nervous system. A new integrative mechanism in synapses (1985) (147)
Wiring and volume transmission in the central nervous system: The concept of closed and open synapses (1996) (142)
Postnatal maternal separation during the stress hyporesponsive period enhances the adrenocortical response to novelty in adult rats by affecting feedback regulation in the CA1 hippocampal field (1998) (142)
Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. (2004) (142)
Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease (2007) (141)
Quantitative autoradiography of central neurotransmitter receptors: methodological and statistical aspects with special reference to computer-assisted image analysis. (1986) (140)
Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. (1975) (137)
Aspects on receptor regulation and isoreceptor identification. (1980) (134)
The neural foundations of aesthetic appreciation (2011) (132)
Adenosine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders (2010) (130)
Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites. (1983) (129)
New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. (1982) (128)
Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactive structures in the paraventricular hypothalamic nucleus of the rat (1985) (124)
Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes (2005) (123)
Endothelin‐1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia (1997) (123)
Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors (1979) (121)
Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes (2016) (120)
Neurotransmitter receptor heteromers and their integrative role in ‘local modules’: The striatal spine module (2007) (119)
Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection (1988) (119)
Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor–receptor interactions (2013) (118)
Dopaminergic Systems in the Brain and Pituitary (1985) (118)
The G Protein-Coupled Receptor Heterodimer Network (GPCR-HetNet) and Its Hub Components (2014) (116)
Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain (2007) (113)
Intramembrane receptor–receptor interactions: a novel principle in molecular medicine (2006) (113)
Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor (1985) (113)
Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat (1984) (108)
Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity (2012) (108)
Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. (2000) (107)
G protein-coupled receptor heterodimerization in the brain. (2013) (105)
Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives (2006) (105)
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats (1989) (102)
Adenosine Receptor Heteromers and their Integrative Role in Striatal Function (2007) (101)
Corticosterone Actions on the Hippocampal Brain‐Derived Neurotrophic Factor Expression are Mediated by Exon IV Promoter (2006) (100)
On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. (1983) (99)
Volume versus wiring transmission in the brain: A new theoretical frame for neuropsychopharmacology (1995) (99)
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive neurons in the rostral medulla oblongata of the adult and old male rat (1988) (98)
Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects. (1984) (97)
Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion. (1984) (95)
Distribution of nicotinic cholinergic receptors in the rat tel- and diencephalon: a quantitative receptor autoradiographical study using [3H]-acetylcholine, [alpha-125I]bungarotoxin and [3H]nicotine. (1988) (95)
Intramembrane Interactions between Neurotensin Receptors and Dopamine D2 Receptors as a Major Mechanism for the Neuroleptic‐like Action of Neurotensin a (1992) (95)
Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. (2011) (94)
Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine (2006) (93)
Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. (1976) (93)
Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices. (2010) (93)
The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural–glial networks (2015) (92)
The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation (2003) (91)
Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field (2014) (90)
On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity (1977) (90)
Aspects of neural plasticity in the central nervous system—I. Computer-assisted image analysis methods (1990) (90)
Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. (2010) (89)
Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. (1986) (88)
Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study (2011) (87)
Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. (2003) (87)
Studies on the cellular localization and distribution of glucocorticoid receptor and estrogen receptor immunoreactivity in the central nervous system of the rat and their relationship to the monoaminergic and peptidergic neurons of the brain. (1987) (86)
The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. (1975) (86)
Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat (1987) (86)
Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function (1986) (86)
Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons (1991) (84)
Dopamine D2 and 5-hydroxytryptamine 5-HT(₂A) receptors assemble into functionally interacting heteromers. (2010) (84)
On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7 receptor antagonist A-438079 (2010) (83)
Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex (1988) (82)
Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. (1992) (82)
GPCR heteromers and their allosteric receptor-receptor interactions. (2012) (82)
Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat (1983) (82)
Effects of acute and long-term treatment with neuroleptics on regional telencephalic neurotensin levels in the male rat (1986) (82)
Receptor-receptor interactions as an integrative mechanism in nerve cells (2007) (80)
Receptor–receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins (2006) (79)
Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease. (2004) (79)
Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes. (2013) (79)
Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Evidence for increases of dopamine turnover in the mesostriatal and mesolimbic dopamine neurons. (1981) (79)
Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. (1983) (78)
Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization (2007) (78)
Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. (2010) (78)
Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets (2015) (77)
On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment. (2011) (77)
Immunohistochemical indications of gastrin releasing peptide - bombesin-like immunoreactivity in the nervous system of the rat. Codistribution with substance P-like immunoreactive nerve terminal systems and coexistence with substance P-like immunoreactivity in dorsal root ganglion cell bodies (1983) (76)
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal‐based model of schizophrenia (2002) (75)
Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion (2004) (74)
Relationships of 5-hydroxytryptamine immunoreactive terminal-like varicosities to 5-hydroxytryptamine-2A receptor-immunoreactive neuronal processes in the rat forebrain (2001) (74)
Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum (2001) (74)
Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders. (1978) (72)
Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat (2005) (72)
Role of electrostatic interaction in receptor-receptor heteromerization (2007) (72)
Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. (2007) (72)
Extrasynaptic Neurotransmission in the Modulation of Brain Function. Focus on the Striatal Neuronal–Glial Networks (2012) (71)
A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. (2010) (71)
Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2 (2004) (71)
Glial and Neuronal Glucocorticoid Receptor Immunoreactive Cell Populations in Developing, Adult, and Aging Brain a (1994) (70)
Volume transmission revisited (2000) (70)
The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor–receptor interactions (2010) (70)
Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes. (2014) (70)
Centrally administered endothelin-1 produces lesions in the brain of the male rat. (1989) (69)
Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain. (2011) (69)
Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. (2003) (69)
Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di- and telencephalon (1987) (68)
Galanin Modulates 5‐Hydroxytryptamine Functions: Focus on Galanin and Galanin Fragment/5‐Hydroxytryptamine1A Receptor Interactions in the Braina (1998) (68)
Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene. (1989) (67)
Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures. (2012) (67)
The functional recovery of damaged brain: The effect of GM1 monosialoganglioside (1984) (67)
Central Glucocorticoid Receptor Immunoreactive Neurons: New Insights into the Endocrine Regulation of the Brain (1987) (67)
On the role of volume transmission and receptor–receptor interactions in social behaviour: Focus on central catecholamine and oxytocin neurons (2012) (66)
Exosomes From Astrocyte Processes: Signaling to Neurons (2019) (65)
Regional differences in glucocorticoid receptor immunoreactivity among neuropeptide Y immunoreactive neurons of the rat brain. (1989) (65)
Interactions between Calmodulin, Adenosine A2A, and Dopamine D2 Receptors* (2009) (65)
NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat (1997) (65)
Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. (1979) (65)
Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease (2015) (65)
Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum (1989) (64)
Hypothalamic temperature during the sleep cycle at different ambient temperatures. (1975) (64)
Neurochemical Changes in the Hippocampus of the Brown Norway Rat During Aging (1997) (64)
Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. (1988) (64)
Somatostatin produces apnea and is localized in medullary respiratory nuclei: a possible role in apneic syndromes (1984) (64)
On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat (1999) (63)
5,7‐DIHYDROXYTRYPTAMINE AS A TOOL TO STUDY THE FUNCTIONAL ROLE OF CENTRAL 5‐HYDROXYTRYPTAMINE NEURONS * (1978) (63)
Molecular mechanisms involved in the adenosine A1 and A2A receptor‐induced neuronal differentiation in neuroblastoma cells and striatal primary cultures (2005) (63)
Aspects on the information handling by the central nervous system: focus on cotransmission in the aged rat brain. (1986) (63)
Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor-receptor interactions in cotransmission. (1986) (63)
ON THE ROLE OF CENTRAL ADRENALINE NEURONS IN CENTRAL CARDIOVASCULAR REGULATION (1980) (61)
Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks (2014) (61)
Increased affinity of dopamine for D2‐like versus D1‐like receptors. Relevance for volume transmission in interpreting PET findings (2012) (60)
Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis. (1978) (60)
Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. (1988) (59)
Interactions among adenosine deaminase, adenosine A1 receptors and dopamine D1 receptors in stably cotransfected fibroblast cells and neurons (2002) (59)
On the existence and function of galanin receptor heteromers in the central nervous system (2012) (59)
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP (2005) (59)
Distribution of dopamine-immunoreactive neurons and their relationships to transmitter and hypothalamic hormone-immunoreactive neuronal systems in the rat mediobasal hypothalamus. A morphometric and microdensitometric analysis (1993) (58)
Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats (1992) (58)
Volume transmission and its different forms in the central nervous system (2013) (58)
Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites. (1983) (58)
Receptor–receptor interactions: A novel concept in brain integration (2010) (57)
G-protein-coupled receptor heteromer dynamics (2010) (57)
Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle. (1984) (56)
Increased endothelin-like immunoreactivity in ibotenic acid-lesioned hippocampal formation of the rat brain. (1989) (55)
How receptor mosaics decode transmitter signals. Possible relevance of cooperativity. (2005) (55)
Distribution of glutamic acid decarboxylase messenger RNA-containing nerve cell populations of the male rat brain. (1990) (55)
Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat (1984) (55)
A method to determine dopamine levels and turnover rate in discrete dopamine nerve terminal systems by quantitative use of dopamine fluorescence obtained by Falck-Hillarp methodology (1979) (55)
Further evidence that methergoline is a central 5-hydroxytryptamine receptor blocking agent (1978) (55)
Moonlighting characteristics of G protein‐coupled receptors: Focus on receptor heteromers and relevance for neurodegeneration (2011) (54)
Allosteric modulation of dopamine D2 receptors by homocysteine. (2006) (54)
The Dopaminergic System (1985) (54)
Receptor-Receptor Interactions (1987) (53)
Evidence for the existence of putative dopamine-, adrenaline- and noradrenaline-containing vagal motor neurons in the brainstem of the rat (1984) (53)
Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum. (2001) (53)
A2A‐D2 receptor–receptor interaction modulates gliotransmitter release from striatal astrocyte processes (2017) (53)
Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover. (1975) (53)
The nigrostriatal DA pathway and Parkinson's disease. (2006) (52)
Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat (2005) (52)
Heterodimers and receptor mosaics of different types of G-protein-coupled receptors. (2008) (52)
Failure of neuropeptide Y in vitro to increase the number of alpha 2-adrenergic binding sites in membranes of medulla oblongata of the spontaneous hypertensive rat. (1983) (52)
Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission (1995) (52)
Transient forebrain ischemia produces multiple deficits in dopamine D1 transmission in the lateral neostriatum of the rat (1989) (52)
The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for l-deprenyl-induced activation of reactive astrocytes (1994) (51)
Polyamines, Ornithine Decarboxylase, and Diamine Oxidase in the Substantia Nigra and Striatum of the Male Rat After Hemitransection (1988) (51)
Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor (2007) (51)
Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade (1987) (50)
Catecholamine turnover changes in hypothalamus and dorsal midline area of the caudal medulla oblongata of spontaneously hypertensive rats (1979) (50)
Studies on neuropeptide-Y catecholamine interactions in central cardiovascular regulation in the alpha-chloralose anaesthetized rat. Evidence for a possible new way of activating the alpha-2 adrenergic transmission line. (1984) (49)
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs (1979) (49)
Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain (1996) (49)
Cellular localization and distribution of dopamine D4 receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks (2008) (49)
A boolean network modelling of receptor mosaics relevance of topology and cooperativity (2006) (48)
New Methods to Evaluate Colocalization of Fluorophores in Immunocytochemical Preparations as Exemplified by a Study on A2A and D2 Receptors in Chinese Hamster Ovary Cells (2005) (48)
Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression (1993) (48)
Diet-induced changes in hypothalamic pro-opio-melanocortin mRNA in the rat hypothalamus (2002) (47)
Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration (2004) (47)
Repeated electroconvulsive shock increases glial fibrillary acidic protein, ornithine decar☐ylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat (1990) (47)
Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic d-amphetamine treatment (1994) (47)
Evidence for a Cardiovascular Role of Central Galanin Neurons: Focus on Interactions with &agr;2‐Adrenergic and Neuropeptide Y Mechanisms (1986) (46)
The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine (1979) (46)
Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias (2005) (46)
Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain Relevance for neurodegenerative diseases and their treatment (2007) (45)
Basic fibroblast growth factor (bFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain (1993) (45)
Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat (2005) (45)
New concepts on the structure of the neuronal networks: The miniaturization and hierarchical organization of the central nervous system (1984) (45)
L-deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain. (1993) (45)
Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats. (1997) (45)
Diversity and Bias through Receptor–Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization (2014) (45)
Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats (1993) (44)
Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine. (1978) (44)
Determinations of catecholamine half-lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry. (1985) (44)
Neuroanatomical methods for the quantitative evaluation of coexistence of transmitters in nerve cells. analysis of the ACTH- and β-endorphin immunoreactive nerve cell bodies of the mediobasal hypothalamus of the rat (1982) (43)
Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. (2013) (43)
Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain (1987) (43)
Evidence for Cholecystokinin‐Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old Rat (1985) (43)
Increased amine turnover in several hypothalamic noradrenaline nerve terminal systems and changes in prolactin secretion in the male rat by exposure to various concentrations of toluene. (1983) (43)
The effect of nicotine on central catecholamine neurons and gonadotropin secretion. I. Studies in the male rat. (1977) (43)
Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase. (1978) (43)
Fluorescence resonance energy transfer-based technologies in the study of protein-protein interactions at the cell surface. (2012) (42)
Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems. (1981) (42)
Trafficking of adenosine A2A and dopamine D2 receptors (2007) (42)
Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment (1983) (42)
Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat (1987) (42)
Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: Relevance for volume transmission (2006) (41)
On the Role of Neuropeptide Y in Information Handling in the Central Nervous System in Normal and Physiopathological States (1990) (41)
Centrally injected neuropeptide Y (13–36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1–36) in the awake male rat (1990) (41)
Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia (2009) (41)
Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors. (1983) (40)
How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. (2008) (40)
Energy gradients for the homeostatic control of brain ECF composition and for VT signal migration: introduction of the tide hypothesis (2004) (40)
Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs. (2014) (40)
The Neurobiology of Imagination: Possible Role of Interaction-Dominant Dynamics and Default Mode Network (2013) (40)
Monosialoganglioside internal ester stimulates the dopaminergic reinnervation of the striatum after unilateral hemitransection in rat (1984) (40)
Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat (1981) (40)
G-protein-coupled receptor type A heteromers as an emerging therapeutic target (2015) (40)
Mosaic, self-similarity logic and biological attraction principles (2009) (39)
Studies on dopamine turnover in ovariectomized or hypo-physectomized female rats. effects of 17β-estradiol benzoate, ethynodioldiacetate and ovine prolactin (1978) (39)
Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex. (2014) (39)
Aspects of neural plasticity in the central nervous system—VII. Theoretical aspects of brain communication and computation (1990) (39)
Evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system. (2015) (39)
The effect of nicotine on central catecholamine neurons and gonadotropin secretion. II. Inhibitory influence of nicotine on LH, FSH and prolactin secretion in the ovariectomized female rat and its relation to regional changes in dopamine and noradrenaline levels and turnover. (1977) (39)
Involvement of central catecholamines in the feedback actions of 17β-estradiolbenzoate on luteinizing hormone secretion in the ovariectomized female rat (1977) (39)
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive nerve terminals and on glucocorticoid receptor-immunoreactive nerve cell nuclei in the paraventricular hypothalamic nucleus in adult and old male rats (1988) (38)
On the role of receptor–receptor interactions and volume transmission in learning and memory (2007) (38)
On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain (1994) (38)
Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type. (1993) (38)
Pre- and postsynaptic features of the central angiotensin systems. Indications for a role of angiotensin peptides in volume transmission and for interactions with central monoamine neurons. (1988) (38)
Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains (2008) (38)
Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat. (1985) (37)
Different classes of volume transmission signals exist in the central nervous system, and are affected by metabolic signals, temperature gradients, and pressure waves (1994) (37)
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. (1990) (37)
The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology (2006) (37)
On the role of glucocorticoid receptors in brain plasticity (1996) (37)
Localization of [125I]endothelin-1 and [125I]endothelin-3 binding sites in the rat brain. (1989) (37)
Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors (1978) (37)
Molecular Basis of Learning and Memory: Modelling Based on Receptor Mosaics (2002) (37)
Galanin/5-HT interactions in the rat central nervous system. Relevance for depression (1991) (37)
Microinjections of subpicomolar amounts of NPY(13–36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY(1–36) and of a NPY Y1 receptor agonist (1993) (37)
Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers (2007) (37)
On the role of the extracellular space on the holistic behavior of the brain (2015) (36)
Uncoupling protein‐2 promotes nigrostriatal dopamine neuronal function (2006) (36)
Vasopressor effects of substance P and C-terminal sequences after intracisternal injection to alpha-chloralose-anaesthetized rats: blockade by a substance P antagonist. (1982) (36)
Understanding neuronal molecular networks builds on neuronal cellular network architecture (2008) (36)
Neurotransmitter Mechanisms in the Control of the Secretion of Hormones from the Anterior Pituitary (1979) (35)
Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat. (1988) (35)
Nicotine-induced increases of noradrenaline turnover in discrete noradrenaline nerve terminal systems of the hypothalamus and the median eminence of the rat and their relationship to changes in the secretion of adenohypophyseal hormones. (1981) (35)
On the Nested Hierarchical Organization of CNS: Basic Characteristics of Neuronal Molecular Networks (2003) (35)
Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury (2001) (35)
International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached? (2010) (35)
Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat. (1989) (35)
Chronic continuous infusion of (−)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat (1996) (34)
Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence (1983) (34)
Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain. (1982) (34)
Central Nervous System and Computation (2011) (34)
Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone. (1985) (34)
One century of progress in neuroscience founded on Golgi and Cajal's outstanding experimental and theoretical contributions (2007) (34)
A simple mathematical model of cooperativity in receptor mosaics based on the "symmetry rule". (2005) (34)
Influence of anterior hypothalamic heating on the duration of fast wave sleep episodes. (1974) (33)
Central Catecholamine‐Neuropeptide Y Interactions at the Pre‐ and Postsynaptic Level in Cardiovascular Centers (1986) (33)
Evidence for a role of neosynthetized putrescine in the increase of glial fibrillary acidic protein immunoreactivity induced by a mechanical lesion in the rat brain (1990) (33)
Effects of chronic toluene exposure on central monoamine and peptide receptors and their interactions in the adult male rat. (1988) (33)
On the Molecular Basis of the Receptor Mosaic Hypothesis of the Engram (2004) (33)
Cholecystokinin Neuron Systems and Their Interactions with the Presynaptic Features of the Dopamine Neuron Systems (1985) (33)
On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain (1995) (33)
How proteins come together in the plasma membrane and function in macromolecular assemblies (2007) (33)
An integrated view on the role of receptor mosaics at perisynaptic level: focus on adenosine A2A, dopamine D2, cannabinoid CB1, and metabotropic glutamate mGlu5 receptors (2010) (33)
Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat. (1982) (32)
Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s disease (2004) (32)
Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development? (2019) (32)
Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis (2005) (32)
The impact of receptor–receptor interactions in heteroreceptor complexes on brain plasticity (2014) (32)
Neuropeptides and central catecholamine systems: interactions in neuroendocrine and central cardiovascular regulation. (1980) (32)
Age-related alterations in tanycytes of the mediobasal hypothalamus of the male rat (1995) (32)
Receptor‐Receptor Interactions and Their Relevance for Receptor Diversity (1995) (32)
On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structures to the neuropeptide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain (1998) (31)
Homocysteine Potentiates Seizures and Cell Loss Induced by Pilocarpine Treatment (2010) (31)
Aβ peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer’s disease (2006) (31)
Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and alpha 2-adrenoceptors. (1989) (31)
Subcortical limbic3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro (1983) (31)
Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression. (2015) (31)
Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. (1983) (31)
Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients (2009) (31)
Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat—mismatches indicate a role of d1 receptors in volume transmission (1988) (31)
GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. (1988) (31)
Receptor-receptor interactions : a new intramembrane integrative mechanism : proceedings of an international symposium held at the Wenner-Gren Center, Stockholm, October 9th-11th, 1986 (1987) (31)
Neuropeptide Y and Central Cardiovascular Regulation (1990) (31)
A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevances for the Alzheimer's disease (2010) (30)
Ganglioside GM1 treatment prevents the effects of subacute exposure to toluene on N-[3 H]propylnorapomorphine binding characteristics in rat striatal membranes (1987) (30)
G protein-coupled receptor-receptor interactions give integrative dynamics to intercellular communication (2018) (30)
Antagonistic regulation of α2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii (1994) (30)
In Vitro Effects of Cocaine on Tunneling Nanotube Formation and Extracellular Vesicle Release in Glioblastoma Cell Cultures (2014) (30)
Mecamylamine induced blockade of nicotine induced inhibition of gonadotrophin and TSH secretion and of nicotine induced increases of catecholamine turnover in the rat hypothalamus. (1980) (30)
G protein-coupled receptor oligomerization for what? (2010) (30)
Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats (1999) (30)
Quantitative Neuroanatomy in Transmitter Research (1985) (30)
l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes. (1984) (29)
Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: Modulation by chronic ganglioside GM1 treatment (1985) (29)
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides. (1985) (29)
Computer-assisted morphometry and microdensitometry of transmitter-identified neurons with special reference to the mesostriatal dopamine pathway. III: Studies on aging processes (1984) (29)
Effects of chronic exposure to cigarette smoke on amine levels and turnover in various hypothalamic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat. (1985) (29)
Evidence for an antagonitic angiotensin II/α2-adrenoceptor interaction in the nucleus tractus solitarii (1994) (29)
Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers. (1987) (29)
G protein-coupled receptor oligomerization and brain integration: Focus on adenosinergic transmission (2012) (29)
Immunocytochemical Demonstration of Angiotensin II and Renin-Like Immunoreactive Nerve Cells in the Hypothalamus. Angiotensin Peptides as Comodulators in Vasopressin and Oxytocin Neurons and Their Regulation of Various Types of Central Catecholamine Nerve Terminal Systems (1982) (29)
Evidence for a modulation by neuropeptide Y of the alpha-2 adrenergic transmission line in central adrenaline synapses. New possibilities for treatment of hypertensive disorders. (1984) (29)
On the expanding terminology in the GPCR field: The meaning of receptor mosaics and receptor heteromers (2010) (29)
Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory (2014) (29)
Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet. (1997) (29)
The effect of dl-, l- and d-Propranolol on central monoamine neurones I. Studies on dopamine mechanisms (1976) (28)
Monoaminergic and Peptidergic Innervation of the Intermedio‐Lateral Horn of the Spinal Cord (1990) (28)
A method to measure the distribution pattern of specific nerve terminals in sampled regions. Studies on tyrosine hydroxylase LHRH, TRH and GIH immunofluorescence. (1977) (28)
The concept of trophic units in the central nervous system (1995) (28)
Corticotropin-releasing factor increases noradrenaline turnover in the median eminence and reduces noradrenaline turnover in the paraventricular region of the hypophysectomized male rat. (1984) (28)
Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat. (1983) (28)
Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection (1990) (28)
Neuroglobin as a regulator of mitochondrial-dependent apoptosis: a bioinformatics analysis. (2014) (28)
Striatal ornithine decarboxylase activity following neurotoxic and mechanical lesions of the mesostriatal dopamine system of the male rat. (1985) (28)
Nicotine-induced FGF-2 mRNA in rat brain is preserved during aging (2004) (28)
On the existence of a global molecular network enmeshing the whole central nervous system: physiological and pathological implications. (2006) (28)
Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex (1987) (28)
Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes (2016) (27)
Glutamate mGlu5-adenosine A2A-dopamine D2 receptor interactions in the striatum. Implications for drug therapy in neuro-psychiatric disorders and drug abuse (2003) (27)
Regional and cellular distribution within the rat prostate of two mRNA species undergoing opposite regulation by androgens. (1992) (27)
A new road to neuroinflammation in Parkinson's disease? (2008) (27)
Morphometrical evidence for a complex organization of tyrosine hydroxylase-,enkephalin- and darpp-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum (1988) (27)
Effects of gangliosides on the functional recovery of damaged brain. (1984) (27)
Nerve cell clusters in dorsal striatum and nucleus accumbens of the male rat demonstrated by glucocorticoid receptor immunoreactivity. (1990) (27)
Partners for adenosine A1 receptors (2007) (27)
Receptor–receptor interactions in central cardiovascular regulation. Focus on neuropeptide/α2-adrenoreceptor interactions in the nucleus tractus solitarius (2006) (26)
Basic fibroblast growth factor and steroid receptors in the aging hippocampus of the Brown Norway rat: Immunocytochemical analysis in combination with stereology (1994) (26)
Differential effect of ganglioside GM1 on rat brain phosphoproteins: potentiation and inhibition of protein phosphorylation regulated by calcium/calmodulin and calcium/phospholipid-dependent protein kinases. (1987) (26)
Studies on aging processes. (1984) (26)
Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine. (1976) (26)
PRECLINICAL STUDIES WITH MODAFINIL. EVIDENCE FOR VIGILANCE ENHANCEMENT ANDNEUROPROTECTION (1996) (26)
Evidence for a selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata of young spontaneous hypertensive rats. (1979) (26)
Somatostatin-induced apnea: Interaction with hypoxia and hypercapnea in the rat (1984) (26)
Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2. (2013) (26)
Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia (2006) (26)
Galanin–neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y1 receptor subtype (2006) (26)
Increases in sulphated glycoprotein-2 mRNA levels in the rat brain after transient forebrain ischemia or partial mesodiencephalic hemitransection. (1993) (25)
Reduction of adrenaline turnover in cardiovascular areas of rat medulla oblongata by clonidine. (1979) (25)
Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat (1993) (25)
On the Role of the Balance of GPCR Homo/ Heteroreceptor Complexes in the Brain (2015) (25)
Art, aesthetics, and the brain (2015) (25)
Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides (2007) (25)
Long distance signalling in volume transmission. Focus on clearance mechanisms. (2000) (25)
Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons. (1984) (25)
Influence of central catecholamines on LHRH-containing pathways. (1978) (25)
Neuronal correlates to consciousness. The “Hall of Mirrors” metaphor describing consciousness as an epiphenomenon of multiple dynamic mosaics of cortical functional modules (2012) (25)
Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes (1994) (25)
Strongly glucocorticoid receptor immunoreactive neurons in the neonatal rat brain. (1991) (25)
Effects of acute central and peripheral administration of nicotine on hypothalamic catecholamine nerve terminal systems and on the secretion of adenohypophyseal hormones in the male rat. (1982) (25)
Transmitter and peptide systems in areas involved in the control of blood pressure. (1984) (25)
Effects of subacute treatment with toluene on cerebrocortical alpha- and beta-adrenergic receptors in the rat. Evidence for an increased number and a reduced affinity of beta-adrenergic receptors. (1987) (25)
On the relationship of 5‐hydroxytryptamine neurons to 5‐hydroxytryptamine 2A receptor‐immunoreactive neuronal processes in the brain stem of rats. A double immunolabelling analysis (1998) (25)
Editorial (Thematic Issue: Understanding the Role of Heteroreceptor Complexes in the Central Nervous System) (2014) (24)
Possible genetic and epigenetic links between human inner speech, schizophrenia and altruism (2012) (24)
Aspects of neural plasticity in the central nervous system—III. Methodological studies on the microdialysis technique (1990) (24)
Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat. (1982) (24)
Neuroglobin, a Factor Playing for Nerve Cell Survival (2016) (24)
Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine (2010) (24)
Pain, Analgesia, and Stress: An Integrated View (1991) (24)
Subunit and region-specific decreases in nicotinic acetylcholine receptor mRNA in the aged rat brain (1999) (24)
Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia (1992) (24)
A new approach to quantitate the density and antigen contents of high densities of transmitter-identified terminals. Immunocytochemical studies on different types of tyrosine hydroxylaxe immunoreactive nerve terminals in nucleus caudatus putamen of the rat (1982) (24)
Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia. (2014) (24)
Spermidine/spermine N1-acetyltransferase mRNA levels show marked and region-specific changes in the early phase after transient forebrain ischemia. (1996) (24)
Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes (2018) (24)
The effect of the ganglioside GM1 on neuronal plasticity (1986) (23)
Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer. (2010) (23)
Maintained activity of single neurons in striate and non-striate areas of the cat visual cortex. (1973) (23)
Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat (1991) (23)
Aspects of neural plasticity in the central nervous system—V. Studies on a model of transient forebrain ischemia in male Sprague-Dawley rats (1990) (23)
Modulation of Dopamine D1 and D2 Transmission Lines in the Central Nervous System (1990) (23)
Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system (1993) (23)
Presynaptic A2-adrenoceptors and neuropeptide Y Y2 receptors inhibit [3H]noradrenaline release from rat hypothalamic synaptosomes via different mechanisms (1995) (23)
A new model of focal brain ischemia based on the intracerebral injection of endothelin-1. (1991) (23)
Possible Mechanisms for the Powerful Actions of Neuropeptides a (1994) (23)
Cellular and synaptic alterations in the aging brain (1990) (23)
A brief appraisal on some aspects of the receptor-receptor interaction (1995) (23)
A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence (2019) (23)
Rapid and discrete changes in hypothalamic catecholamine nerve terminal systems induced by audiogenic stress, and their modulation by nicotine-relationship to neuroendocrine function. (1983) (23)
Evidence for the existence of a population of arcuate neurons costoring choline acetyltransferase and tyrosine hydroxylase immunoreactivities in the male rat (1989) (23)
Pertussis toxin treatment counteracts the cardiovascular effects of neuropeptide Y and clonidine in the awake unrestrained rat (1989) (23)
Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs. (1996) (23)
Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat (1986) (22)
Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption (2007) (22)
Dopamine D4 receptor activation decreases the expression of μ‐opioid receptors in the rat striatum (2007) (22)
Corticosterone strongly increases the affinity of dorsal raphe 5-HT1A receptors (2004) (22)
Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat (1999) (22)
Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family. (2011) (22)
The mesolimbic dopamine system: Evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population (1980) (22)
Morphometric characterization of transmitter-identified nerve cell groups: Analysis of mesencephalic 5-HT nerve cell bodies (1982) (22)
Calcium-permeable AMPA receptors trigger vesicular glutamate release from Bergmann gliosomes (2015) (22)
Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain (1988) (22)
Adenosine A 2A -Dopamine D 2 Receptor-Receptor Heteromerization QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER* □ S (2003) (22)
CENTRAL CATECHOLAMINE SYSTEMS AND NEUROENDOCRINE REGULATION. CONTROLLERS OF ANTERIOR PITUITARY SECRETION (1979) (22)
The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway (2004) (21)
Effects of antidepressant drugs on cerebral serotonin receptor mechanisms. (2009) (21)
Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation (2011) (21)
Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: Selective protection by sulpiride in the striatum (1986) (21)
Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems (2002) (21)
Muscarinic acetylcholine receptor-interacting proteins (mAChRIPs): targeting the receptorsome. (2012) (21)
Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems: Further Evidence for Volume Transmission (2001) (21)
Studies on central D1 receptors role in volume transmission, neuroendrocrine regulation and release of noradrenaline. (1988) (21)
Neurochemical alterations but not nerve cell loss in aged rat neostriatum (1993) (21)
Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides (2005) (21)
Coinjections of NPY(1–36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline (1994) (21)
Information handling by the brain: proposal of a new “paradigm” involving the roamer type of volume transmission and the tunneling nanotube type of wiring transmission (2014) (21)
Bioinformatics and mathematical modelling in the study of receptor-receptor interactions and receptor oligomerization: focus on adenosine receptors. (2011) (21)
Differential Sensitivity of A2A and Especially D2 Receptor Trafficking to Cocaine Compared with Lipid Rafts in Cotransfected CHO Cell Lines. Novel Actions of Cocaine Independent of the DA Transporter (2010) (21)
Neuronal plasticity and ageing processes in the frame of the 'Red Queen Theory'. (1992) (21)
Regional increases in ornithine decarboxylase mRNA levels in the rat brain after partial mesodiencephalic hemitransection as revealed by in situ hybridization histochemistry (1991) (20)
Understanding the role of heteroreceptor complexes in the central nervous system. (2014) (20)
Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms (2011) (20)
Monoaminergic and Peptidergic Innervation of the Intermedio‐Lateral Horn of the Spinal Cord (1990) (20)
Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development. (2009) (20)
The Receptor Mosaic Hypothesis of the Engram: Possible Relevance of Boolean Network Modelling (1996) (20)
Dopamine D1 and D2 Receptor Immunoreactivities in the Arcuate-Median Eminence Complex and their Link to the Tubero-Infundibular Dopamine Neurons (2014) (20)
Long-lasting reduction of glucocorticoid receptor immunoreactivity in the hippocampal field CA1 but not in the dentate gyrus after neonatal treatment with corticosterone in the rat. (1990) (20)
A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevance for Alzheimer's disease. (2010) (20)
Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases (2007) (20)
Intraventricular injections of renin increase amine turnover in the tuberoinfundibular dopamine neurons and reduce the secretion of prolactin in the male rat. (1982) (20)
New dimensions of connectomics and network plasticity in the central nervous system (2017) (19)
Evidence for a regional distribution of hyaluronic acid in the rat brain using a highly specific hyaluronic acid recognizing protein (1994) (19)
On the Biochemistry and Pharmacology of Hallucinogens (1976) (19)
Selective reduction of glucocorticoid receptor immunoreactivity in the hippocampal formation and central amygdaloid nucleus of the aged rat (1991) (19)
Effects of subacute toluene exposure on protein phosphorylation levels in rat frontoparietal and striatal membranes. (1987) (19)
Effects of polyamine synthesis blockade on neuronal loss and astroglial reaction after transient forebrain ischemia (1993) (19)
Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment. (2014) (19)
A new method to quantify catecholamine stores visualized by means of the Falck-Hillarp technique (1978) (19)
Luteinizing hormone-releasing hormone increases dopamine turnover in the lateral palisade zone of the median eminence and reduces noradrenaline turnover in the nuc. Preopticus medialis of the hypophysectomized male rat (1984) (19)
CentraIIy administered endothelin‐I produces apnoea in the a‐chloralose‐anaesthetized male rat (1989) (19)
Partial di-mesencephalic hemitransections produce disappearance of [3H]nicotine binding in discrete regions of rat brain. (1987) (19)
Changes in glucocorticoid receptor immunoreactivity after adrenalectomy and corticosterone treatment in the rat testis (1995) (18)
Evidence for interactions between striatal cholecystokinin and glutamate receptors. CCK-8 in vitro produces a marked downregulation of 3H-glutamate binding sites in striatal membranes. (1983) (18)
Principles for the Hormone Regulation of Wiring Transmission and Volume Transmission in the Central Nervous System (1988) (18)
Implications of the ‘Energide’ concept for communication and information handling in the central nervous system (2009) (18)
Fuxe, K. et al. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural Transm. 114, 49-75 (2007) (18)
Morphometric evaluation of populations of neuronal profiles (cell bodies, dendrites, and nerve terminals) in the central nervous system (1992) (18)
Regulation of endocrine function by the nicotinic cholinergic receptor. (1990) (18)
EFFECTS OF ANDROGENIC AND ADRENOCORTICAL STEROIDS ON HYPOTHALAMIC AND PREOPTIC CATECHOLAMINE NERVE TERMINALS AND ON THE SECRETION OF ANTERIOR PITUITARY HORMONES (1981) (18)
Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity. (1986) (18)
Central Glucocorticoid Receptors and Neuronal Plasticity (1994) (18)
Intracisternal administration of cholecystokinin-8 counteracts the central cardiovascular effects of adrenaline and NPY. A study based on the coexistence of cholecystokinin, phenylethanolamine N-methyltransferase and neuropeptide Y immunoreactivity in neurons of the nucleus tractus solitarius (1987) (18)
Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity. (1983) (18)
Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia (1991) (18)
Aspects on the Integrative Capabilities of the Central Nervous System: Evidence for ‘Volume Transmission’ and its Possible Relevance for Receptor-Receptor Interactions (1987) (18)
Intercalated and paracapsular cell islands of the adult rat amygdala: A combined rapid-Golgi, ultrastructural, and immunohistochemical account (2012) (18)
Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. (1988) (18)
Some aspects of the communicational and computational organization of the brain. (1989) (18)
Somatostatin induced apnoea: prevention by central and peripheral administration of the opiate receptor blocking agent naloxone. (1985) (18)
Long‐Term Modulation By Postnatal Oxytocin of the α2‐Adrenoceptor Agonist Binding Sites in Central Autonomic Regions and the Role of Prenatal Stress (2004) (18)
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. (1985) (18)
The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs. (1985) (17)
A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of ‘predictive psychic homeostasis’ (2011) (17)
Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. (2007) (17)
Regeneration in the central nervous system: concepts and facts. (1988) (17)
Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry (2013) (17)
The Existence of FGFR1–5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity (2012) (17)
Effects of Nicotine and Exposure to Cigarette Smoke on Discrete Dopamine and Noradrenaline Nerve Terminal Systems of the Telencephalon and Diencephalon of the Rat: Relationship to Reward Mechanisms and Neuroendocrine Functions and Distribution of Nicotinic Binding Sites in Brain (1987) (17)
Computer-assisted image analysis techniques allow a characterization of the compartments within the basal ganglia. Focus on functional compartments produced by d-amphetamine activation of the c-fos gene and its relationship to the glucocorticoid receptor (1991) (17)
Morphometric evaluation of the coexistence of renin-like and oxytocin-like immunoreactivity in nerve cells of the paraventricular hypothalamic nucleus of the rat (1982) (17)
Presence of renin-like immunoreactivity in oxytocin immunoreactive nerve cells of the paraventricular and supraoptic nuclei in the rat hypothalamus. (1982) (17)
Internalization of Intracerebrally Administered Porcine Galanin (1–29) by a Discrete Nerve Cell Population in the Hippocampus of the Rat (2000) (17)
Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke (2005) (17)
THE ROLE OF CENTRAL CATECHOLAMINE PATHWAYS IN SPONTANEOUS AND RENAL HYPERTENSION IN RATS (1980) (16)
The use of amine fluorescence histochemistry in the study of drugs, especially morphine, on the CNS (1975) (16)
On the interactive role of central noradrenaline neurons and corticosterone in two-way active avoidance acquisition in the rat (1981) (16)
Effects of acute haloperidol treatment on regional catecholamine levels and utilization in rats exposed to toluene. (1988) (16)
Acute sino-aortic denervation in rats produces a selective increase of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and a reduction of adrenaline levels in the anterior and posterior hypothalamus. (1981) (16)
Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol (1989) (16)
On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain Modulation (2013) (16)
Receptor—receptor interactions: possible new mechanisms for the action of some antidepressant drugs (1983) (16)
Opposite patterns of age-associated changes in neurons and glial cells of the thalamus of human brain (2008) (16)
Increased potency of neuropeptide y to antagonize α 2-adrenoceptor function in the nucleus tractus solitarii of the spontaneously hypertensive rat (1997) (16)
Principles for the morphological characterization of transmitter-identified nerve cell groups (1982) (16)
Centrally administered galanin reduces dopamine utilization in the median eminence and increases dopamine utilization in the medial neostriatum of the male rat. (1989) (15)
Changes in striatal μ and δ opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study (1991) (15)
Does the human brain have unique genetically determined networks coding logical and ethical principles and aesthetics? From Plato to novel mirror networks (2007) (15)
QUANTITATIVE COMPARISONS OF AMINE FLUORESCENCE IN CORTICAL NORADRENALINE TERMINALS USING SMEAR PREPARATIONS (1974) (15)
D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release (1988) (15)
Receptor mosaics of neural and immune communication: Possible implications for basal ganglia functions (2008) (15)
Galanin/5-HT Receptor Interactions. A New Integrative Mechanism in the Control of 5-HT Neurotransmission in the Central Nervous System (1990) (15)
Near‐infrared laser photons induce glutamate release from cerebrocortical nerve terminals (2018) (15)
Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. (2007) (15)
Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone. (1979) (15)
A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides (2011) (15)
Siagoside Selectively Attenuates Morphological and Functional Striatal Impairments Induced by Transient Forebrain Ischemia in Rats (1992) (14)
Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity. (1986) (14)
Development of Quantitative Methods for the Evaluation of the Entity of Coexistence of Neuroactive Substances in Nerve Terminal Populations in Discrete Areas of the Central Nervous System: Evidence for Hormonal Regulation of Cotransmission (1985) (14)
On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity. (1980) (14)
A morphometric analysis of transmitter identified dendrites and nerve terminals (1982) (14)
Receptor-Receptor Interactions in the Central Nervous System (2018) (14)
The brain as a “hyper-network”: the key role of neural networks as main producers of the integrated brain actions especially via the “broadcasted” neuroconnectomics (2018) (14)
Endothelin-1-Induced Lesions in the Brain as a New Model of Focal Ischemia (1991) (14)
β-Amyloid Fibrillation and/or Hyperhomocysteinemia Modify Striatal Patterns of Hyaluronic Acid and Dermatan Sulfate: Possible Role in the Pathogenesis of Alzheimers Disease (2010) (14)
Adenosine A 2 A Receptor and Dopamine D 3 Receptor Interactions : Evidence of Functional A 2 A / D 3 Heteromeric Complexes (2005) (14)
Regulation of the mesocortical dopamine neurons. (1977) (14)
Effects of indole-pyruvic acid on sleep and food intake in the rat. (1990) (13)
Demonstration of NPY transmitter receptor mismatches in the central nervous system of the male rat. (1989) (13)
Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat (1999) (13)
Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat (1991) (13)
Aspects of neural plasticity in the central nervous system—IV. Chemical anatomical studies on the aging brain (1990) (13)
Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons. (1990) (13)
Effects of transient forebrain ischemia on peptidergic neurons and astroglial cells: evidence for recovery of peptide immunoreactivities in neocortex and striatum but not hippocampal formation (2004) (13)
Fibroblast Growth Factor-2, Ganglioside GM1 and the Trophic Regulation of the Basal Ganglia. Focus on the Nigrostriatal Dopamine Neurons (1994) (13)
Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence on PMS-induced ovulation in the immature rat. II. A pharmacological analysis. (1977) (13)
Survival of adenohypophyseal homologous transplants in the rat striatum associated with prolactin-like immunoreactivity in the surrounding neuropil of the striatum (1988) (13)
Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat (1989) (13)
Morphometrical and Microdensitometrical Studies on Monoaminergic and Peptidergic Neurons in the Aging Brain (1985) (12)
Evidence for an antagonistic angiotensin II/alpha 2-adrenoceptor interaction in the nucleus tractus solitarii. (1994) (12)
Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat (1996) (12)
Evidence for stabilization of cortical 5HT neurotransmission by chronic treatment with antidepressant drugs: induction of a high and low affinity component in 3H-5HT binding sites. (1982) (12)
Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence of PMS-induced ovulation in the immature rat. I. Catecholamine turnover changes in relation to the critical period. (1977) (12)
A new hypothesis on memory - a possible role of local circuits in the formation of the memory trace. (1981) (12)
Role of Monoamines in the Control of Gonadotrophin Secretion1 (1976) (12)
Effects of chronic treatment with l-sulpiride and haloperidol on central monoaminergic mechanisms. (1980) (12)
Centrally administered neuropeptide Y fails to increase food intake but enhances hypoalgesia in spontaneously hypertensive rats (1993) (12)
Counteraction of NPY-induced c-Fos expression in the nucleus tractus solitarii by α2 receptor agonists (1995) (12)
GABA and benzodiazepine receptors. Studies on their localization in the hippocampus and their interaction with central dopamine neurons in the rat brain. (1981) (12)
The novel cyclooxygenase-2 inhibitor GW637185X protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity (2008) (11)
Increased vasopressor potency of the centrally injected neuropeptide Y fragment 13-36 in the adult spontaneously hypertensive awake male rat of the Wistar-Kyoto strain. (1990) (11)
Receptor–Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis (2018) (11)
Regional distribution of neural cell adhesion molecule immunoreactivity in the adult rat telencephalon and diencephalon. Partial colocalization with heparan sulfate proteoglycan immunoreactivity (1997) (11)
On the role of neuropeptide Y receptors of the Y2 type in the control of hypothalamic catecholaminergic mechanisms and neuroendocrine function. Central effects of the NPY fragment (13–36) (1991) (11)
Galanin increases potassium evoked release of [3H]5-hydroxytryptamine from rat hypothalamic synaptosomal preparations (1991) (11)
Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes. (1984) (11)
Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis. (1989) (11)
A study on the effects of interaction between naloxone and 2-Br-α-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serum (1979) (11)
Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis (2005) (11)
Neurotensin-like immunoreactivity in odontoblasts and their processes in rat maxillary molar teeth and the effect of pulpotomy (1995) (10)
Angiotensin II reduces the affinity of [3H]para-aminoclonidine binding sites in membrane preparations from the rat dorsomedial medulla oblongata. (1988) (10)
The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity. (1976) (10)
Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system (2012) (10)
Theoretical Considerations on the Topological Organization of Receptor Mosaics (2009) (10)
Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous system. (1986) (10)
Aspects on the integrative actions of the brain from neural networks to “brain-body medicine” (2012) (10)
Reciprocal interactions between α2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat (1989) (10)
Cell–Cell Communication Through the Extracellular Space (2009) (10)
Effects of chronic administration of antidepressant drugs on central serotonergic receptor mechanisms (1983) (10)
The mis-exaptation of the prediction capability of humans and emergence of intolerant religious beliefs (2017) (10)
Evidence for receptors for hyaluronan in discrete nerve cell populations of the brain (1996) (10)
Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes (1995) (10)
Central 5-HT neurons as targets for antidepressant drug action: differential modulation of 5-HT receptor populations in the central nervous system of the rat. (1984) (10)
Morphometrical analysis of the distribution of luteinizing hormone-releasing hormone and tyrosine hydroxylase-immunoreactive nerve terminals within the lateral palisade zone of the median eminence of the male rat (1983) (10)
Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles (2015) (9)
On the Role of Central Catecholamine and 5-Hydroxytryptamine Neurons in Neuroendocrine Regulation (1975) (9)
EFFECTS OF ESTROGEN AND PROGESTERONE ON CENTRAL α-AND β-ADRENERGIC RECEPTORS IN OVARIECTOMIZED RATS: EVIDENCE FOR GONADAL STEROID RECEPTOR REGULATION OF BRAIN α- AND β-ADRENERGIC RECEPTORS (1981) (9)
Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii. (1994) (9)
Possible role of receptor heteromers in multiple sclerosis (2009) (9)
On the cellular localization and distribution of the ganglioside GM1 in the rat brain as revealed by immunofluorescence histochemistry of cholera toxin binding sites. (1989) (9)
ACTIONS OF ERGOT DERIVATIVES AT DOPAMINE SYNAPSES (1979) (9)
The effect of nicotine on central catecholamine neurons and gonadotropin secretion. III. Studies on prepubertal female rats treated with pregnant mare serum gonadotropin. (1977) (9)
EFFECTS OF ESTROGEN AND COMBINED TREATMENT WITH ESTROGEN AND PROGESTERONE ON CENTRAL DOPAMINE, NORADRENALINE AND ADRENALINE NERVE TERMINAL SYSTEMS OF THE OVARIECTOMIZED RAT. RELATIONSHIP OF CHANGES IN AMINE TURNOVER TO CHANGES IN LH AND PROLACTIN SECRETION AND IN SEXUAL BEHAVIOUR (1981) (9)
Selective modulation of the NPY receptors of the Y2 subtype by α2 receptors in the nucleus tractus solitarii of the rat. A cardiovascular and quantitative receptor autoradiographical analysis (1994) (9)
The effect of dl-, l- and d-propranolol on central monoamine neurones II. Studies on noradrenaline mechanisms (1976) (9)
Adenosine A2A-dopamine D2 receptor-receptor interaction in neurons and astrocytes: Evidence and perspectives. (2020) (9)
Neurochemical mechanisms underlying the neuroendocrine actions of nicotine: focus on the plasticity of central cholinergic nicotinic receptors. (1989) (9)
Quantitative Autoradiography as a Tool to Study Receptors in Neural Tissue. Studies on 3H-Ouabain Binding Sites and Correlation with Synaptic Protein Phosphorylation in Different Brain Areas (1985) (9)
Does a Self-Similarity Logic Shape the Organization of the Nervous System? (2016) (9)
Intracisternal administration of avian pancreatic polypeptide lowers respiration rate and enhances the clonidine induced reduction of respiration rate in alpha-chloralose anesthetized rats: possible interactions with an alpha 2-adrenergic receptor. (1982) (8)
Quantitative Microfluorimetry and Semiquantitative Immunocytochemistry as Tools in the Analysis of Transmitter Identified Neurons (1985) (8)
New Evidence for the Morphofunctional Recovery of Striatal Function by Ganglioside GM1 Treatment Following a Partial Hemitransection of Rats. Studies on Dopamine Neurons and Protein Phosphorylation (1986) (8)
Principles for the Construction of the Software for Image Analysis of Transmitter-Identified Neurons (1985) (8)
Central monoamine synapses as sites of action for ergot drugs. (1980) (8)
Heterodimer of A2A and Oxytocin Receptors Regulating Glutamate Release in Adult Striatal Astrocytes (2022) (8)
Common key-signals in learning and neurodegeneration: focus on excito-amino acids, β-amyloid peptides and α-synuclein (2009) (8)
Nigrostriatal dopamine neurons, D1 transmission in basal and ischemic states and protective effects of gangliosides. (1990) (8)
Lesions and transplantation (1991) (8)
Studies on the Involvement of Polyamines for the Trophic Actions of the Ganglioside GM1 in Mechanically and 6-hydroxydopamine Lesioned Rats. Evidence for a Permissive Role of Putrescine (1986) (8)
Regional and cellular distribution of spermidine/spermine N 1-acetyltransferase (SSAT) mRNA in the rat central nervous system (1996) (8)
Acute continuous exposure to cigarette smoke produces discrete changes in cholecystokinin and substance P levels in the hypothalamus and preoptic area of the male rat. (1985) (8)
Indole-pyruvic acid increases 5-hydroxyindoleacetic (1990) (8)
Selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and increase of hypothalamic adrenaline levels in the Lyon strain of genetically hypertensive rats. (1982) (8)
Volume Transmission and the Russian-Doll Organization of Brain Cell Networks: Aspects of Their Integrative Actions (2014) (8)
Evidence that intracisternal injections of cholecystokinin-8 counteracts the cardiovascular effects of intracisternally injected adrenaline and neuropeptide Y in the alpha-chloralose anaesthetized rat. (1986) (8)
The Effect of Chronic Nicotine Treatment on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Degeneration of Nigrostriatal Dopamine Neurons in the Black Mouse (1991) (8)
On the Role of Receptor-Receptor Interactions in Synaptic Transmission: Biochemical and Autoradiographical Studies on the Interactions between α2-adrenergic and Neuropeptide Y Receptors in the Nucleus Tractus Solitarius (1987) (7)
Chronic continuous infusion of nicotine increases the disappearance of choline acetyltranferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix (1994) (7)
Aspects of neural plasticity in the central nervous system—II. Numerical classification in neuroanatomy (1990) (7)
Receptor-Receptor Interactions (1987) (7)
Increased diffusion of prolactin-like material into the brain neuropil from homologous adenohypophyseal transplants in the rat neostriatum after a 6-OH-dopamine induced degeneration of the mesostriatal dopamine neurons (1989) (7)
beta-Amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: Possible role in the pathogenesis of Alzheimer's disease. (2010) (7)
A New Integrative Theory of Brain-Body-Ecosystem Medicine: From the Hippocratic Holistic View of Medicine to Our Modern Society (2019) (7)
The effects of subchronic antidepressant drug treatment on the secretion of adenohypophyseal hormones and of corticosterone in the male rat. (1982) (7)
Evidence for a modulatory influence of centrally administered substance P on a 5-hydroxytryptamine-mediated behavioural response in the male rat. (1985) (7)
Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides. (2007) (7)
Homeostasis and the concept of 'interstitial fluids hierarchy': Relevance of cerebrospinal fluid sodium concentrations and brain temperature control (Review) (2017) (7)
Effects of transient forebrain ischaemia on vasoactive intestinal polypeptide‐immunoreactive neuronal populations in the frontoparietal cortex and hippocampal formation of the male rat (1989) (7)
Involvement of D1 dopamine receptors in the nicotine-induced noradrenaline release from hypothalamic and preoptic noradrenaline nerve terminal systems (1988) (7)
Prolactin-lowering drugs. (1981) (7)
Image analysis and the determination of codistribution and coexistence of neuroactive substances in nerve terminal populations (1985) (7)
Energy gradients for VT-signal migration in the CNS: studies on melanocortin receptors, mitochondrial uncoupling proteins and food intake. (2004) (7)
Immobilization stress induces vasodepressor and altered neuroendocrine responses in the adult stroke-prone spontaneously hypertensive male rat. (1993) (6)
Effects of chronic sino-aortic denervation in male rats on regional catecholamine levels and turnover and on neuroendocrine function. (1983) (6)
Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat (1993) (6)
Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat (2004) (6)
Interactions of a partial ergoline with dopamine receptors in vivo and in vitro. (1983) (6)
Communication and computation in the central nervous system. (1991) (6)
Temporal changes in sulphated glycoprotein-2 (clusterin) and ornithine decarboxylase mRNA levels in the rat testis after ethane-dimethane sulphonate-induced degeneration of Leydig cells. (1995) (6)
"Neuro-semeiotics" and "free-energy minimization" suggest a unified perspective for integrative brain actions: focus on receptor heteromers and Roamer type of volume transmission. (2014) (6)
P.6.c.001 Dopamine D2 receptor dynamic and modulation in the D2R-Sigma 1 heteroreceptor complexes: role in cocaine action (2015) (6)
Immunocytochemical Studies on Some Brain Regions in a Rat Model of Incomplete Cerebral Ischemia. Relationship to Behavior and Aging (1989) (6)
Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat (1989) (6)
Neuropeptide Y enhances the inhibitory effects of clonidine on3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat (2005) (6)
Involvement of α 2-receptors in the analgesia induced by transient forebrain ischemia in rats (1993) (6)
ACUTE EFFECTS OF CATECHOLESTROGENS ON HYPOTHALAMIC AND MEDIAN EMINENCE CATECHOLAMINES AND ANTERIOR PITUITARY GLAND LUTEINIZING HORMONE AND PROLACTIN SECRETION IN THE OVARIECTOMIZED RAT (1981) (6)
On the key role played by altered protein conformation in Parkinson’s disease (2008) (6)
Neurochemical and Behavioral Studies on L-dopa Toxicity in the Model of Manganese Lesioned Nigrostriatal Pathway in the Rat: Evidence for a Protective Effect of the GM1 Lactone Siagoside (1994) (6)
Counteraction of NYP-induced c-Fos expression in the nucleus tractus solitarii by alpha 2 receptor agonists. (1995) (6)
Studies on Excitatory Amino Acid Receptors and Their Interactions and Regulation of Pre- and Postsynaptic Dopaminergic Mechanism in the Rat Telencephalon (1983) (6)
Aspects of neural plasticity in the central nervous system—VI. Studies of the effects of gangliosides on brain metabolic lesions (1990) (6)
Effects of Chronic GM1 Ganglioside Treatment on Nigral Dopamine Cell Bodies and Dendrites in Experimental Rats Using Image Analysis — Relationship to the Pharmacokinetic Properties (1985) (5)
Naloxone potentiation of 2-Br-α-ergocryptine (CB 154) effects on GH secretion in man (1979) (5)
Immunocytochemical Studies on Glucocorticoid Receptor (1994) (5)
The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease (2006) (5)
Evidence for discrete alterations in central cardiovascular catecholamine and neuropeptide Y immunoreactive neurons in aged male rats and in genetically hypertensive male rats of the Lyon strain. (1987) (5)
Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone (1981) (5)
Receptor autoradiograhical evidence of a preferential reduction of binding sites for atrial natriuretic factor in renal papilla of the spontaneously hypertensive rat (1988) (5)
Protein Phosphorylation in Rat Pineal Gland and Its Regulation in Supersensitive and Subsensitive States (1987) (5)
Studies on Enkephalinergic Mechanisms in Cardiovascular Centers of the Medulla Oblongata of the Rat and their Interactions with Centrally Administered Neuropeptide Y (1988) (5)
Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats. (1977) (5)
Action of beta(4-chlorphenyl)GABA, gamma-hydroxybutyrolactone, and apomorphine on central dopamine neurons. (1977) (5)
Codistribution of choleratoxin binding sites and tyrosine hydroxylase/FGF-2 immunoreactive nigral nerve cells. (1993) (5)
Involvement of alpha 2-receptors in the analgesia induced by transient forebrain ischemia in rats. (1993) (5)
The basal ganglia—from neuronal systems to molecular networks (2008) (5)
Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors (1990) (5)
Homeostasis and the concept of 'interstitial fluids hierarchy': Relevance of cerebrospinal fluid sodium concentrations and brain temperature control (Review). (2017) (5)
Generalized presence of a PEC-60-like peptide in catecholamine neurones. (1994) (5)
Effects of sulpiride isomers on the control of anterior pituitary secretion in normal man (1979) (5)
Brain integration: From networks to the cellular–molecular level (2012) (5)
Functional roles of three cues that provide nonsynaptic modes of communication in the brain: electromagnetic field, oxygen, and carbon dioxide. (2018) (5)
Evidence for the existence of pulses of dopamine in the extracellular space of the rat striatum. (2000) (5)
A method for rostrocaudal integration of morphometric information from transmitter-identified cell groups. A morphometrical identification and description of 5-HT cell groups in the medulla oblongata of the rat (1984) (5)
Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity (1983) (5)
A new interpretative paradigm for Conformational Protein Diseases. (2013) (5)
Possible Functional Meaning of the Coexistence of Monoamines and Peptides in the Same Neurons. A Study on the Interactions Between Cholecystokinin-8 and Dopamine in the Brain (1983) (5)
Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors. (1989) (4)
Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study. (1996) (4)
Changes in pituitary-adrenal activity regulate the central vasodepressor responses induced by neuropeptide Y and adrenaline in the awake unrestrained male rat. (1991) (4)
Development of computer-assisted simulation procedure to analyze receptor modulatory processes (2005) (4)
Acute and subchronic corticosterone treatment differentially modulates subcortical limbic and neostriatal nicotinic cholinergic receptors (1990) (4)
Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysis (2005) (4)
Effects of transient forebrain ischemia on vasoactive intestinal polypeptide immunoreactive neuronal populations in the frontoparietal cortex and hippocampal formation of the male rat (1989) (4)
Possible mixed agonist-antagonist activity of d-sulpiride at dopamine receptor level in man (1981) (4)
Possible Relevance of Receptor-Receptor Interactions between Viral- and Host-Coded Receptors for Viral-Induced Disease (2007) (4)
Central dopamine agonist activity on the 8-α-amino-ergoline CU 32-085 (1985) (4)
Steroidal regulation of coexisting neuronal messengers: Focus on double and triple immunolabeling procedures and on indirect evaluation of coexistence (1992) (4)
Ganglioside GM1 modulation of calcium/calmodulin-dependent protein kinase II activity and autophosphorylation (1991) (4)
Peptidergic and catecholaminergic mechanisms in central blood pressure control. (1980) (4)
Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis. (2000) (4)
Receptor–Receptor Interactions and Glial Cell Functions with a Special Focus on G Protein-Coupled Receptors (2021) (4)
PEC-60, a novel porcine 60-residue intestinal peptide, reduces dopamine utilization in discrete parts of the neostriatum of the male rat following an intracerebroventricular injection. (1991) (3)
From the hierarchical organization of the central nervous system to the hierarchical aspects of biocodes (2019) (3)
Are maternal mitochondria the selfish entities that are masters of the cells of eukaryotic multicellular organisms? (2009) (3)
The Nigro-Striatal DA Neurons and Mechanisms of Their Degeneration in Parkinson’s Disease (2008) (3)
Neuronal plasticity: a major factor in the restoration of brain function after injury. (1984) (3)
Ibotenate as a Tool in Neurobiology. Studies on Dopaminergic and Cholecystokinin Immunoreactive Neurons after Ibotenate Induced Lesions (1983) (3)
On the Role of Receptor-Receptor Interactions in Central Cardiovascular Regulation: Functional Studies on the Interactions between α2-adrenergic and Neuropeptide Y Receptors in the Rat Medulla Oblongata (1987) (3)
Evidence for nuclear ornithine decarboxylase activity in different brain regions of the male rat (1989) (3)
Receptor autoradiographical evidence of a preferential reduction of binding sites for atrial natriuretic factor in renal papilla of the spontaneously hypertensive rat. (1988) (3)
Intercellular Communication in the Central Nervous System as Deduced by Chemical Neuroanatomy and Quantitative Analysis of Images: Impact on Neuropharmacology (2022) (3)
Effects of the interaction between methysergide and clonidine on growth hormone and prolactin secretion in normal man (1981) (3)
Dopamine Receptor Oligomerization (2010) (3)
Inner speech mis-exaptation can cause the “Hubris” that speeds up ecosystem over-exploitation (2018) (3)
L.01 Novel strategies for treatment of schizophrenia and Parkinson's disease. Focus on receptor-receptor interactions in the basal ganglia (2003) (3)
Neuropeptide Y increases the inhibitory effects of clonidine on potassium evoked3H-noradrenaline but not3H-5-hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague-Dawley rat (2005) (3)
The multi-facet aspects of cell sentience and their relevance for the integrative brain actions: role of membrane protein energy landscape (2016) (3)
Quantitative neuroanatomy in transmitter research : proceedings of an international symposium held at the Wenner-Gren Center, Stockholm, May 3-4, 1984 (1985) (3)
Effects of centrally administered clonidine and neuropeptide Y on arterial blood pressure in the rat after transient forebrain ischemia. (1990) (3)
Reduction of [3H]nicotine binding by clonidine in membrane preparations of the rat cerebral cortex. (1988) (3)
Involvement of Gangliosides in Neuroplasticity of the Central Nervous System in Physiological and Pathological Conditions (1992) (3)
Special issue: Proceedings of the Wenner-Gren Foundation symposium - Receptor-receptor interactions among heptaspanning membrane receptors: From structure to function - Concluding remarks (2005) (3)
The G Protein-Coupled Receptor Heterodimer Network (2014) (3)
Volume Transmission in Transmitter Peptide Costoring Neurons in the Medulla Oblongata (2019) (2)
Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas. (1980) (2)
Intercellular communication in the brain (2007) (2)
Central dopamine agonist activity on the 8-alpha-amino-ergoline CU 32-085. (1985) (2)
Related Responses Between Dopamine Synapses and Astrocytes in the Rat Striatum After Global Cerebral Ischemia: A Morphometric and Microdensitometric Study (1989) (2)
Reduced inhibitory effects of clonidine and neuropeptide Y on3H-noradrenaline release from synaptosomes of the medulla oblongata of the spontaneously hypertensive rat (2005) (2)
EVIDENCE FOR FUNCTIONAL SYNAPTIC PLASTICITY IN THE CENTRAL NERVOUS SYSTEM MAD ITS ALTERATION DURING AGING AND IN PHYSIOPATHOLOGICAL CONDITIONS (1984) (2)
Man is a “Rope” Stretched Between Virosphere and Humanoid Robots: On the Urgent Need of an Ethical Code for Ecosystem Survival (2021) (2)
PEC-60 AND RELATED PEPTIDES AS HORMONES IN THE GASTROINTESTINAL TRACT AND THE IMMUNE SYSTEM AND AS GENERALIZED COTRANSMITTERS IN CATECHOLAMINE NEURONS (1994) (2)
Neuroendocrine and trophic actions of nicotine (1988) (2)
Heteroreceptor Complexes in the Central Nervous System. Focus on Their Role in Pain Modulation (2015) (2)
Art as a Human “Instinct-Like” behavior Emerging from the Exaptation of the Communication Processes (2015) (2)
Statistical analysis of single neuron spontaneous discharge, in the cat visual cortex. (1970) (2)
Characterization of Striatal Ibotenate Lesions and of 6-Hydroxydopamine Induced Nigral Lesions by Morphometric and Densitometric Approaches (1983) (2)
Indole-pyruvic acid increases 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid and frontoparietal cortex of the rat: a microdialysis study. (1990) (2)
ON THE ROLE OF NORADRENALINE AND ADRENALINE NEURON SYSTEMS IN CONTROL OF CENTRAL CARDIOVASCULAR FUNCTIONS (1979) (2)
The MPTP Model of Parkinson's Disease in the Mouse. Modafinil—a New Potential Neuroprotective Agent (1994) (2)
The inhibitory effect of methergoline on LAE-32-induced head-twitches in mice (1977) (2)
Central catecholamine neurons and exposure to dichloromethane. Selective changes in amine levels and turnover in tel- and diencephalic DA and NA nerve terminal systems and in the secretion of anterior pituitary hormones in the male rat. (1984) (2)
Heteromerization of Adenosine and Dopamine Receptor Subtypes: Relevance for Neuronal Integration in Normal and Pathological States (2002) (2)
Vasopressor effects of intracerebroventricular injections of PEC-60, a novel porcine 60-residue intestinal peptide, in the awake unrestrained male rat (1990) (2)
Acute intermittent nicotine treatment produces a reduction in the total number of FGF-2 immunoreactive astroglial cells in the substantia nigra of the rat: a stereological analysis (2004) (2)
EVIDENCE FOR STRUCTURAL PLASTICITY IN THE NIGROSTRIATAL DOPAMINE NEURONS: MORPHOMETRICAL AND BIOCHEMICAL EVIDENCE FOR A TROPHIC ACTION OF GANGLIOSIDES ON PARTIALLY LESIONED NIGROSTRIATAL DOPAMINE NEURONS (1984) (2)
Exposure to Strong Static Magnetic Fields Induces Hypoactivity in Weaning Mice (1991) (2)
Regional variations in 5-HT receptor populations and in 3H-imipramine binding sites in their responses to chronic antidepressant treatment (1983) (2)
Effect of methergoline on body temperature in mice (1977) (2)
Centrally administered endothelin-1 produces apnoea in the alpha-chloralose-anaesthetized male rat. (1989) (1)
Morphometric Evaluation of Populations of Neuronal Profiles in the Central Nervous System (1991) (1)
P.1.g.067 The GalR1–GalR2 heteroreceptor complex can be the receptor for galanin fragment 1–15 (2014) (1)
Interactions of nicotine and pentobarbitone in the regulation of telencephalic and hypothalamic catecholamine levels and turnover and of adenohypophyseal hormone secretion in the normal male rat (1982) (1)
Description of the maintained activity of single units in the cat visual cortex in terms of a three component model. (1973) (1)
Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man. (1979) (1)
Effects of Acute and Chronic Treatment with Imipramine on 5-Hydroxytryptamine and 5-Hydroxytryptamine Comodulators in Central 5-Hydroxytryptamine Neurons and on Glucocorticoid Receptors in Central Monoaminergic Neurons: a Morphometrical and Microdensitometrical Analysis (1988) (1)
Morphological and Biochemical Studies on Neuropeptide Y (NPY) and Adrenergic Mechanisms and their Interactions in Central Cardiovascular Regulation (1986) (1)
Neuron-glia cross talk in rat striatum after transient forebrain ischemia. (1997) (1)
Further Evidence for a Vasodepressor Role of Neuropeptide Y (NPY) and Adrenaline (A) in the Central Nervous System (CNS) of the Rat (1986) (1)
Failure of naloxone to modify the inhibitory effect of clonidine on insulin secretion (1983) (1)
The balance and integration of different forms of volume and wiring transmission in the CNS. Relevance for schizophrenia (2014) (1)
The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. (1975) (1)
Striatal astrocytic processes and glutamate release: effects of homocysteine and A2A-D2 receptor-receptor interaction (2017) (1)
On the functional role of neuropeptides in various types of central monoamine pathways (1983) (1)
Spontaneous firing of single neurons of the cat visual cortex. (1970) (1)
Physiological and Logical Brain Functionalities: A Hypothesis for a Self-Referential Brain Activity (2002) (1)
Aspects on the Role of Neuropeptide Y and Atrial Peptides in Control of Vascular Resistance (1986) (1)
Modulating brain integrative actions as a new perspective on pharmacological approaches to neuropsychiatric diseases (2023) (1)
Changes in striatal mu and delta opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study. (1991) (1)
Mechanisms Underlying the Protective Effects of Chronic Nicotine Treatment Against Degeneration of Central Dopamine Neurons by Mechanical Lesions (1991) (1)
Retraction: Borroto-Escuela et al., The Existence of FGFR1-5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity (2013) (1)
Subject Index Vol. 16 (suppl 1), 1978 (1978) (1)
Speaker 4: Dasiel Borroto – Escuela, Sweden (2016) (0)
Contents, Vol. 24, 1977 (1977) (0)
[Analysis of a parameter suitable for measuring the viscose-elastic properties of excised lungs]. (1973) (0)
An international conference on Brain Plasticity, Aging and Neuropsychiatric disorders hosted by the Ramon Areces Foundation. Preface. (2009) (0)
Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function (1987) (0)
P.1.b.005 On the balance and distribution of adenosine A2A homoreceptor and A1-A2A isoreceptor complexes in the hippocampus of the rat brain (2015) (0)
Introductory remarks (2007) (0)
[Effects of acute localized lesions in nervous structures of the brain on ambulatory activity in the guinea pig]. (1973) (0)
Contributors to Volume 22 (1994) (0)
HYPOTHALAMO- PITUITARY INTERACTIONS. (1979) (0)
[Electrophysiological study of the "spontaneous" discharge of single neurons in the visual cortex of the non-anesthetized cat]. (1969) (0)
E.07.01 Multiple D2 heteroreceptor complexes in the ventral striatum modulating the brain circuit to the prefrontal cortex – a new target for treatment of schizophrenia (2015) (0)
Modulation effects of ganglioside gm 1 treatment on the glucocorticoid receptor immunoreactivity in the dentate neurons of the hippocampus in insulin induced coma in the male rat (1986) (0)
399 – FURTHER STUDIES ON THE INHIBITORY GABERGIC CONTROL OF MESO-LIMBIC DOPAMINE NEURONS. POSSIBILITY OF IMPROVING TREATMENT OF SCHIZOPHRENIA BY COMBINED TREATMENT WITH NEUROLEPTICS AND GABERGIC DRUGS (1977) (0)
NERVE TERMINALS IN SAMPLED REGIONS. STUDIES ON TYROSINE HYDROXYLASE LHRH, TRH AND GIH (1977) (0)
A2A-D2 receptor-receptor interaction in striatal astrocyte processes: homocysteine modulation of glutamate release (2017) (0)
FibroblastGrowthFactorReceptor 1-5-Hydroxytryptamine1AHeteroreceptorComplexesand TheirEnhancementofHippocampalPlasticity (2012) (0)
Principles for the morphological characterization of transmitter-identified nerve cell groups L.F. Agnati, K. Fuxe, I. Zini, F. Benfenati, T. Hökfelt and J. de Mey, J. neurosci. Meth., 6 (1982) 157–167 (1982) (0)
Evidence for the existence of the A2A-A1 heteroreceptor complex in the rat brain, and comparison of its distribution to that of the A2A-A2A homoreceptor complex (2015) (0)
[Comparison of a parameter proposed for measurement of the pulmonary viscous-elastic properties and compliance in excised rat lungs]. (1973) (0)
196 – PHARMACOLOGICAL EVIDENCE FOR THE EXISTENCE OF A DOPAMINE (DA) RECEPTOR IN THE MEDIAN EMINENCE INHIBITING LUTEINIZING HORMONE RELEASING FACTOR (LRF) SECRETION (1977) (0)
Possible involvement of G-proteins in the regulation of striatal dopamine D2 receptor affinity by cholecystokinin octapeptide (1997) (0)
Increase of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems via allosteric receptor-receptor interaction (2015) (0)
Interactions between VIP and norepinephrine, ergot alkaloids and prostanoids in mouse cerebral cortex (1987) (0)
Studies on the effects of homocysteine (hcy) and Aβ peptides on human glioma cells (2006) (0)
Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154). (1981) (0)
[Central control of the locomotor activity of guinea pigs]. (1974) (0)
In Vitro Effects of Cocaine on Tunneling Nanotube Formation and Extracellular Vesicle Release in Glioblastoma Cell Cultures (2014) (0)
Subject Index Vol. 24, 1977 (1977) (0)
In memoriam (1986) (0)
400 – ACTI0NS 0F BENZODIAZEPINES ON GABERGIC AND CATECHOLAMINERGIC MECHANISMS. EVIDENCE FOR INCREASED GABERGIC TRANSMISSION (1977) (0)
S.03.04 FGFR1–5-HT1A receptor heterocomplexes: relevance for neuroplasticity and depression (2014) (0)
The receptor–receptor interactions within the cytokine receptor superfamily. Role in neuroinflammation and beyond (2014) (0)
Native A2A-D2 heterodimers: modulation of glutamate release from striatal astrocyte processes (2016) (0)
882 – BLOCKADE OF CENTRAL 5-HYDROXYTRYPTAMINE RECEPTORS BY SEVERAL TYPES OF ANTIDEPRESSANT DRUGS. POSSIBLE INVOLVEMENT IN THEIR THERAPEUTIC ACTIONS (1978) (0)
Computer assisted image analysis of transmitter receptors (1985) (0)
A measure representative of the variability in real time to the spontaneous activity of neurons in the cat visual cortex. (1971) (0)
Effects of Transient Global Cerebral Ischemia on Peptide Neuronal Populations in Different Brain Regions and on Behavioral Performances in Rats (1989) (0)
Role of Serotonin (and Coexisting Peptides) in the Action Mechanism of Antidepressant Drugs (1989) (0)
Theoretical implications of tolerance development in DA, ACh and GABA turnover after neuroleptic chronic treatment. (1981) (0)
[Quantitative study of the "spontaneous" electric activity of single neurons of the visual cortex of the non-anesthetized cat]. (1969) (0)
Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes (2018) (0)
On the use of automatic image analysis in the demonstration of transmitter identified nerve cell clusters in the central nervous system (1985) (0)
Analysis and Quantification of GPCR Allosteric Receptor–Receptor Interactions Using Radioligand Binding Assays: The A2AR-D2R Heteroreceptor Complex Example (2018) (0)
Responses of Neostriatal Dopaminoceptive Cells to the Ischemic Insult (1994) (0)
Morphological and Functional Adaptation of Basal Ganglia Neurons after Cerebral Ischemia (1994) (0)
Aesthetic Evaluation of Art: A Formal Approach-Oxford Scholarship (2016) (0)
Corrigendum to “Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles” [Physiol. Behav. 142 (2015) 79–84] (2015) (0)
Transient forebrain ischemia induces analgesia in the rat: Evidence for aα2-adrenoceptor mediated mechanism (1990) (0)
Morphometrical and microdensitometrical studies on peptide immunoreactivities in methylazoxymethanol prenatal treated rats (1989) (0)
[Behavior of delayed compliance in excised rat lungs]. (1973) (0)
Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes (2023) (0)
Foreword (1994) (0)
Cyclic nucleotide- and calcium-dependent protein phosphorylation in rat pineal gland: physiological and pharmacological regulation. (1986) (0)
Book received (1992) (0)
Neuropeptide Y (NPY) and adrenaline (A) interactions in the central control of arterial blood pressure (ABP) in the male rat (1993) (0)
Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets (2015) (0)
MODULATION BY CHRONIC ANTIDEPRESSANT TREATMENT OF CENTRAL SEROTONERGIC RECEPTORS (1984) (0)
Brain Structure and Function: Insights from Chemical Neuroanatomy (2023) (0)
[Brief review on the physiological significance of pulmonary surfactant]. (1973) (0)
The treatment of neurodegenerative diseases and the astrocytokinetic drug (1994) (0)
Receptor-receptor interactions and microvesicle exchange as mechanisms modulating signaling between neurons and astrocytes (2023) (0)
New Aspects on the Morphometrical Characterization at Cell Body and Terminal Level of Transmitter Identified Nerve Populations Using Computer-assisted Image Analysis (1989) (0)
GM1 Ganglioside Treatment Affects the Plasticity of Striatal Dopamine Receptors (1986) (0)
The characterization of the dopaminergic profile of EMD 23,448, an indolyl-3-butylamine: Selective actions on presynaptic and supersensitive postsynaptic DA receptor populations (2005) (0)
Morphometrical and microdensitometrical studies on VIP and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate (1989) (0)
Subject Index Vol. 41, 1985 (1985) (0)
Concluding remarks (2007) (0)
Chronic but not acute uridine treatment reduces haloperidol-induced dopamine release in neostriatum as studied by intracerebral microdialysis (1990) (0)
[Apparatus for insufflation and desufflation at a controlled rate of a given volume into the excised rat lung]. (1974) (0)
APORPHINES. 14. DOPAMINERGIC AND ANTINOCICEPTIVE ACTIVITY OF APORPHINE DERIVATIVES. SYNTHESIS OF 10-HYDROXYAPORPHINES AND 10-HYDROXY-N-PROPYLNORAPORPHINE (1976) (0)
G-Protein-Coupled Receptors Heterodimers and Receptor Mosaics of Different Types of (2016) (0)
REVIEW ARTICLE Receptor Mosaics and Their Intramembrane Receptor-Receptor Interactions: Molecular Integration in Transmission and Novel Targets for Drug Development (2009) (0)
From Gilgamesh’s quest for immortality to everlasting cloud hyper-collective mind: ethical implications for artificial intelligence (2022) (0)
[Study of delayed compliance in excised rat lungs]. (1973) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Luigi Francesco Agnati?

Luigi Francesco Agnati is affiliated with the following schools: